Literature DB >> 7685953

Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.

S Takaya1, O Bronsther, K Abu-Elmagd, H Ramos, J J Fung, S Todo, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7685953      PMCID： PMC2994248     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  21 in total

1.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

2.  Prolongation of pig-to-dog renal xenograft survival by modification of the inflammatory mediator response.

Authors:  L Makowka; C Miller; P Chapchap; L Podesta; C Pan; D Pressley; V Mazzaferro; C O Esquivel; S Todo; B Banner
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

3.  Analysis of prostaglandin E2 effect on T lymphocyte activation. Abrogation of prostaglandin E2 inhibitory effect by the tumor promotor 12.0 tetradecanoyl phorbol-13 acetate.

Authors:  S Chouaib; R J Robb; K Welte; B Dupont
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

4.  Prostaglandins modulate macrophage Ia expression.

Authors:  D S Snyder; D I Beller; E R Unanue
Journal:  Nature       Date:  1982-09-09       Impact factor: 49.962

5.  Selective enhancement of thromboxane in macrophages and kidneys in cyclosporine-induced nephrotoxicity. Dietary protection by fish oil.

Authors:  T S Rogers; L Elzinga; W M Bennett; V E Kelley
Journal:  Transplantation       Date:  1988-01       Impact factor: 4.939

6.  Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.

Authors:  G T Makoul; D R Robinson; A K Bhalla; L H Glimcher
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

7.  Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.

Authors:  L Makowka; W Lopatin; T Gilas; J Falk; M J Phillips; R Falk
Journal:  Clin Nephrol       Date:  1986       Impact factor: 0.975

8.  PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats.

Authors:  B Ryffel; P Donatsch; P Hiestand; M J Mihatsch
Journal:  Clin Nephrol       Date:  1986       Impact factor: 0.975

9.  99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.

Authors:  G B Klintmalm; W C Klingensmith; S Iwatsuki; G P Schröter; T E Starzl
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

10.  Prostaglandin E inhibits the production of human interleukin 2.

Authors:  R S Rappaport; G R Dodge
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307
View more
  5 in total

1.  The Future of Xenotransplantation.

Authors:  Thomas E Starzl
Journal:  Ann Surg       Date:  1992-10-01       Impact factor: 12.969

2.  A cost analysis of alprostadil in liver transplantation.

Authors:  D G Smith; K S Henley; C S Remmert; S L Hass; I D McLaren
Journal:  Pharmacoeconomics       Date:  1996-06       Impact factor: 4.981

3.  Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.

Authors:  S Takaya; H Doyle; S Todo; W Irish; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-04       Impact factor: 1.066

Review 4.  The biological basis of and strategies for clinical xenotransplantation.

Authors:  T E Starzl; L A Valdivia; N Murase; A J Demetris; P Fontes; A S Rao; R Manez; I R Marino; S Todo; A W Thomson
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

5.  Baboon-to-human liver transplantation.

Authors:  T E Starzl; J Fung; A Tzakis; S Todo; A J Demetris; I R Marino; H Doyle; A Zeevi; V Warty; M Michaels
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.